Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665028 | SCV000789083 | uncertain significance | Alstrom syndrome | 2016-12-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000665028 | SCV001020745 | benign | Alstrom syndrome | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002386141 | SCV002693692 | likely benign | Cardiovascular phenotype | 2022-06-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000665028 | SCV001465806 | likely benign | Alstrom syndrome | 2020-05-05 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV001706700 | SCV001921859 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001706700 | SCV001972817 | likely benign | not provided | no assertion criteria provided | clinical testing |